Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TLR2 | O60603 | 1/20 | 0.39 |
| ▸ | ERN1 | O75460 | 1/20 | 0.39 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.39 |
| ▸ | TLR6 | Q9Y2C9 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 4/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.35 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.35 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.34 |
| ▸ | SRC | P12931 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15077421 | 0.87 | ALDH1A1 (0.42) | MCHR1ALDH1A1HPGDHTTSMN1; SMN2 | |
| SCHEMBL19519745 | 0.85 | MCHR1 (0.44) | MCHR1ALDH1A1HPGDHTTSMN1; SMN2 | |
| SCHEMBL11673199 | 0.83 | ALDH1A1 (0.53) | MCHR1ALDH1A1HPGDHTTSMN1; SMN2 | |
| SCHEMBL8940219 | 0.83 | ERN1 (0.43) | MCHR1ALDH1A1HPGDHTTSMN1; SMN2 | |
| SCHEMBL17828376 | 0.83 | TLR2 (0.44) | MCHR1ALDH1A1HPGDHTTSMN1; SMN2 | |
| SCHEMBL19777979 | 0.82 | ALDH1A1 (0.36) | ALDH1A1HPGDHTTSMN1; SMN2TLR2 | |
| SCHEMBL5483924 | 0.81 | ERN1 (0.58) | MCHR1ALDH1A1HPGDHTTSMN1; SMN2 | |
| SCHEMBL17805508 | 0.81 | ALDH1A1 (0.36) | MCHR1ALDH1A1HPGDHTTSMN1; SMN2 | |
| SCHEMBL19777996 | 0.80 | TLR2 (0.40) | ALDH1A1HPGDHTTSMN1; SMN2TLR2 | |
| SCHEMBL662857 | 0.80 | SMN1; SMN2 (0.41) | ALDH1A1HPGDHTTSMN1; SMN2TLR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9676796-B2 | Tricyclic benzoxaborole compound, preparation method and use thereof | DONG-A ST CO., LTD. (KR) | 2017-06-13 | — | — | US | disclosed |
| US-20160168167-A1 | Tricyclic Benzoxaborole Compound, Preparation Method and Use Thereof | DONG-A ST CO., LTD. (KR) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168167-A1 | Tricyclic Benzoxaborole Compound, Preparation Method and Use Thereof | CYP2C19, CYP2C9, TBCB | MCHR1 3707/4885ALDH1A1 3448/4885HPGD 2200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.